Brain Cell Types: Alzheimer’s & Parkinson’s Research Breakthrough
Unlocking the Brain’s Complexity: Scientists Cultivate Hundreds of Novel Nerve Cell Types
Basel, Switzerland – In a critically important leap forward for neurological research, scientists at ETH Zurich have successfully generated over 400 distinct types of nerve cells in a laboratory setting. This breakthrough, detailed in a recent publication, promises to revolutionize our understanding of the brain and pave the way for more effective treatments for a wide range of neurological disorders.
For years, researchers have utilized nerve cells derived from stem cells to study diseases like Alzheimer’s and Parkinson’s. Though, a critical limitation has been the lack of precise identification of the specific neuron types being used. “Researchers have often ignored which precise types of neuron they are working with,” explains Barbara Treutlein, Professor at ETH zurich’s Department of Biosystems Science and Engineering. “If we want to develop cell culture models for diseases and disorders such as Alzheimer’s, parkinson’s and depression, we need to take the specific type of nerve cell involved into consideration.”
The key to this advancement lies in a systematic screening approach. Treutlein and her team utilized human induced pluripotent stem cells, originally derived from blood cells. Through genetic engineering, they activated specific neuronal regulator genes and exposed thes cells to various morphogens – signaling molecules crucial for embryonic development that dictate cell positioning and fate. By systematically testing seven different morphogens in a multitude of combinations and concentrations, the researchers created nearly 200 distinct experimental conditions, ultimately yielding over 400 unique nerve cell types.
To validate their findings, the team employed a multi-faceted analysis. They examined the genetic activity (RNA) of individual cells, observed their external morphology, and assessed their functional properties, including the types and quantities of cellular appendages and the electrical impulses they emitted. Crucially, they compared this data with existing databases of neurons from the human brain. This allowed them to identify the generated cell types, classifying them by their origin in the peripheral nervous system or specific brain regions, and even by their sensory functions, such as perceiving pain, cold, or movement.
While the researchers acknowledge they are still a considerable distance from replicating the full diversity of the human brain’s thousands of neuron types in vitro,this achievement represents a substantial expansion of available cell models. These in-vitro neurons hold immense potential for pharmaceutical research, offering a platform to test the efficacy of new drug compounds without the need for animal testing. Furthermore, the long-term vision includes developing cell culture models for complex conditions like schizophrenia, epilepsy, sleep disorders, and multiple sclerosis, with the ultimate goal of developing cures.Looking ahead, these cultivated nerve cells could also be instrumental in cell replacement therapy, a promising approach to repair brain damage by replacing diseased or lost neurons with healthy, lab-grown cells.
Though, a significant challenge remains: many of the experiments produced a mixture of different nerve cell types. The ETH Zurich team is now focused on refining their methodology to ensure that each experimental condition yields a single, specific cell type, a crucial step towards unlocking the full potential of this groundbreaking research.